490 related articles for article (PubMed ID: 28437520)
21. [Caffeine citrate utilization for treatment of apnea in French neonatal units].
Ducrocq S; Biran-Mucignat V; Lebas F; Baudon JJ; Gold F
Arch Pediatr; 2006 Oct; 13(10):1305-8. PubMed ID: 16872813
[TBL] [Abstract][Full Text] [Related]
22. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
Dobson NR; Hunt CE
Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
[TBL] [Abstract][Full Text] [Related]
23. The use of caffeine for the treatment of apnea of prematurity and bradycardia in a holoprosencephalic child with cleft lip and palate.
Kumar M; Chawla R; Haloi P; Singh M
J Clin Anesth; 2013 Dec; 25(8):678-9. PubMed ID: 24100116
[No Abstract] [Full Text] [Related]
24. Caffeine for apnea of prematurity.
Hand IL; Noble LM
N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
[No Abstract] [Full Text] [Related]
25. [Apnea of prematurity: what's new?].
Moriette G; Lescure S; El Ayoubi M; Lopez E
Arch Pediatr; 2010 Feb; 17(2):186-90. PubMed ID: 19944573
[TBL] [Abstract][Full Text] [Related]
26. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
[TBL] [Abstract][Full Text] [Related]
27. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
Schmidt B
Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
[TBL] [Abstract][Full Text] [Related]
28. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
[TBL] [Abstract][Full Text] [Related]
29. Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa.
Ekhaguere OA; Ayede AI; Ezeaka CV
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101182. PubMed ID: 33272903
[TBL] [Abstract][Full Text] [Related]
30. Caffeine citrate: a review of its use in apnoea of prematurity.
Comer AM; Perry CM; Figgitt DP
Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
[TBL] [Abstract][Full Text] [Related]
31. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
[TBL] [Abstract][Full Text] [Related]
32. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
[TBL] [Abstract][Full Text] [Related]
33. Predicting severe motor impairment in preterm children at age 5 years.
Synnes A; Anderson PJ; Grunau RE; Dewey D; Moddemann D; Tin W; Davis PG; Doyle LW; Foster G; Khairy M; Nwaesei C; Schmidt B;
Arch Dis Child; 2015 Aug; 100(8):748-53. PubMed ID: 25784749
[TBL] [Abstract][Full Text] [Related]
34. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
[TBL] [Abstract][Full Text] [Related]
35. Caffeine controversies.
Gentle SJ; Travers CP; Carlo WA
Curr Opin Pediatr; 2018 Apr; 30(2):177-181. PubMed ID: 29346141
[TBL] [Abstract][Full Text] [Related]
36. Childhood respiratory outcomes after neonatal caffeine therapy.
Cheong JLY; Doyle LW
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101158. PubMed ID: 33127315
[TBL] [Abstract][Full Text] [Related]
37. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
[TBL] [Abstract][Full Text] [Related]
38. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial.
Schmidt B; Whyte RK; Asztalos EV; Moddemann D; Poets C; Rabi Y; Solimano A; Roberts RS;
JAMA; 2013 May; 309(20):2111-20. PubMed ID: 23644995
[TBL] [Abstract][Full Text] [Related]
39. The effect of caffeine citrate on neural breathing pattern in preterm infants.
Parikka V; Beck J; Zhai Q; Leppäsalo J; Lehtonen L; Soukka H
Early Hum Dev; 2015 Oct; 91(10):565-8. PubMed ID: 26217936
[TBL] [Abstract][Full Text] [Related]
40. Self-reported Quality of Life at Middle School Age in Survivors of Very Preterm Birth: Results From the Caffeine for Apnea of Prematurity Trial.
Schmidt B; Anderson PJ; Asztalos EV; Doyle LW; Grunau RE; Moddemann D; Roberts RS
JAMA Pediatr; 2019 May; 173(5):487-489. PubMed ID: 30830144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
